Mechanism of Action and Advantages
Interferon inducers prompt the body's cells to produce their own protective proteins. Unlike the administration of exogenous or recombinant proteins, this approach offers two key advantages:
- A fully native protein is synthesized, devoid of antigenicity—the immune system will not generate neutralizing antibodies against it.
- The risk of hyperinterferonemia (a toxic excess of interferon in the bloodstream) is completely eliminated.
In addition to the primary immunomodulatory action, many agents in this group possess direct antiviral activity.
Synthetic Interferon Inducers
This is an extensive group of medications used for the prophylaxis and treatment of influenza, ARVI, viral hepatitis, and herpesvirus infections (including cytomegalovirus).
- Tilorone (Amixin, Lavomax). Triggers the synthesis of all interferon types (alpha, beta, gamma), stimulates humoral immunity (antibody production), and normalizes the balance of T-helper and T-suppressor cells. It is also used for viral encephalomyelitis and in the complex therapy of chlamydiosis. Administered orally after meals.
- Meglumine acridone acetate (Cycloferon). A low-molecular-weight compound with a combined mechanism of action. It not only induces interferon but also directly attacks the virus by disrupting genome replication, suppressing viral protein synthesis, and blocking the incorporation of nucleic acids into capsids. Administered enterally and parenterally. Used in the complex therapy of HIV infection.
- Kagocel. Stimulates the production of "late interferon" (a mixture of alpha and beta fractions). An important pharmacodynamic rule: for maximum effect, administration must begin no later than the 4th day from the onset of an acute infection. Approved for children over 3 years of age.
- Engallivirin / Imidazolyl ethanamide pentandioic acid (Ingavirin). Features a triple mechanism: fights viruses, modulates immunity (activates cytotoxic lymphocytes and NK cells), and relieves inflammation by suppressing pro-inflammatory cytokines (TNF-alpha, IL-1). Active against influenza A and B, parainfluenza, adenovirus, and respiratory syncytial infections.
- Umifenovir (Arbidol). Combines immunomodulation with specific antiviral activity. Blocks viral fusion by binding to viral hemagglutinin and preventing the fusion of its lipid envelope with the host cell membrane. Effective against influenza viruses and coronaviruses (including the SARS pathogen).
Natural Preparations and Adjuvants
Natural inducers are used for coronaviruses, herpesvirus infections, and acute intestinal infections (such as rotavirus) in children over 3 years of age. The general rule for enteral administration is orally, before meals.
- Sodium ribonucleate (Ridostin). A natural compound administered parenterally (intramuscularly, subcutaneously). Indicated for influenza, herpes simplex, rabies, and urogenital chlamydiosis.
- Allokin-alpha. Administered subcutaneously; the primary indication is chronic genital herpes.
- Megosin. Applied topically as a 3% ointment for cutaneous forms of herpes.
Interestingly, agents from entirely different pharmacological groups also exhibit interferonogenic activity. For example, caffeine, bendazole, papaverine, theophylline, and dipyridamole are capable of stimulating immunity, which is why they are sometimes prescribed as adjunctive agents for the prevention and treatment of viral diseases.
Adverse Effects
The use of interferon inducers and other immunotropic drugs may be accompanied by several adverse reactions. Allergic manifestations are the most common. Additionally, the following may occur:
- General toxic reactions: fever (hyperthermia), chills, headache.
- Hematological changes: a transient decrease in blood leukocyte levels (leukopenia), which is eventually replaced by compensatory leukocytosis.
- Musculoskeletal manifestations: muscle pain (myalgia).
- Gastrointestinal disturbances: diarrhea, abdominal pain.